Blocking a single gene stopped Candida auris from growing. TRK1 helps the fungus take up potassium needed to colonize skin, making it a possible therapeutic target. doi.org/hb736f
A multidisciplinary team of researchers at the University of Wisconsin–Madison has identified a promising new therapeutic candidate against Candida auris, an emerging fungal pathogen that has alarmed health officials worldwide because of its ability to resist multiple antifungal drugs and spread rapidly through hospitals and care facilities.
